株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

マイコプラズマ検査の世界市場:2020年~2024年

Global Mycoplasma Testing Market 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 635697
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.88円で換算しております。
マイコプラズマ検査の世界市場:2020年~2024年 Global Mycoplasma Testing Market 2020-2024
出版日: 2020年04月28日 ページ情報: 英文 120 Pages
概要

世界のマイコプラズマ検査市場は、2020年から2024年にかけて11%のCAGRで推移し、市場規模は4億4,557万米ドルに達すると予測されています。バイオ医薬品の研究開発の増加や、マイコプラズマ検査に対する財政的支援の増加、リアルタイムマイコプラズマ検査の導入拡大などによって当市場の成長が促進されています。

当レポートでは、世界のマイコプラズマ検査市場を調査し、市場の概要、製品・エンドユーザー・地域別の市場規模の推移と予測、市場動向、市場の成長要因および課題の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模
  • 市場の見通し

ファイブフォース分析

市場セグメンテーション:製品別

  • 市場区分:製品別
  • 市場比較:製品別
  • 消耗品
  • システム
  • 市場機会:製品別

市場セグメンテーション:エンドユーザー別

  • 市場区分:エンドユーザー別
  • 市場比較:エンドユーザー別
  • 医薬品開発業務受託機関(CRO)
  • 学術研究機関
  • 細胞バンク
  • その他
  • 市場機会:エンドユーザー別

顧客情勢

市場セグメンテーション:地域別

  • 市場区分:地域別
  • 市場比較:地域別
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会:地域別
  • ボリューム成長 - 需要主導の成長
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • ベンダー情勢
  • 創造的破壊の状況

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Agilent Technologies Inc.
  • ATCC
  • Charles River Laboratories International Inc.
  • F. Hoffmann-La Roche Ltd.
  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Norgen Biotek Corp.
  • Thermo Fisher Scientific Inc.

付録

目次
Product Code: IRTNTR43492

Technavio has been monitoring the mycoplasma testing market and it is poised to grow by $ 445.57 million during 2020-2024 progressing at a CAGR of 11% during the forecast period. Our reports on mycoplasma testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing focus on R&D of biopharmaceuticals, increasing initiatives and funding for mycoplasma testing and rise in adoption of real-time mycoplasma testing. In addition, increasing focus on R&D of biopharmaceuticals is anticipated to boost the growth of the market as well.

The mycoplasma testing market analysis includes end-user segment and geographic landscapes

Technavio's ‘ mycoplasma testing market ’ is segmented as below:

By End-user:

  • Pharmaceutical and biotechnology companies
  • Cros
  • Cell banks
  • Academic research institutes
  • Others

By Geographic Landscape:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing M&A and partnerships between CROs, and pharmaceutical and biotechnology companies as one of the prime reasons driving the mycoplasma testing market growth during the next few years. Also, increasing healthcare expenditure and technological advances will lead to sizable demand in the market.

"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our mycoplasma testing market covers the following areas:

  • Mycoplasma testing market sizing
  • Mycoplasma testing market forecast
  • Mycoplasma testing market industry analysis"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mycoplasma testing market vendors that include Agilent Technologies Inc., ATCC, Becton, Dickinson and Co., Charles River Laboratories International Inc., F. Hoffmann-La Roche Ltd., InvivoGen, Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., and Thermo Fisher Scientific Inc.. Also, the mycoplasma testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Force Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Consumables - Market size and forecast 2019-2024
  • Systems - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by End-user

  • Pharmaceutical and biotechnology companies
  • CROs
  • Academic research institutes
  • Cell banks
  • Others

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver - demand led growth
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • ATCC
  • Charles River Laboratories International Inc.
  • F. Hoffmann-La Roche Ltd.
  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Norgen Biotek Corp.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Product - Market share 2019-2024 (%)
  • 22: Comparison by Product
  • 23: Consumables - Market size and forecast 2019-2024 ($ million)
  • 24: Consumables - Year-over-year growth 2019-2024 (%)
  • 25: Systems - Market size and forecast 2019-2024 ($ million)
  • 26: Systems - Year-over-year growth 2019-2024 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2019-2024 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2019-2024 ($ million)
  • 32: North America - Year-over-year growth 2019-2024 (%)
  • 33: Europe - Market size and forecast 2019-2024 ($ million)
  • 34: Europe - Year-over-year growth 2019-2024 (%)
  • 35: Asia - Market size and forecast 2019-2024 ($ million)
  • 36: Asia - Year-over-year growth 2019-2024 (%)
  • 37: ROW - Market size and forecast 2019-2024 ($ million)
  • 38: ROW - Year-over-year growth 2019-2024 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Agilent Technologies Inc. - Overview
  • 48: Agilent Technologies Inc. - Business segments
  • 49: Agilent Technologies Inc. - Key offerings
  • 50: Agilent Technologies Inc. - Key customers
  • 51: Agilent Technologies Inc. - Segment focus
  • 52: ATCC - Overview
  • 53: ATCC - Product and service
  • 54: ATCC - Key offerings
  • 55: ATCC - Key customers
  • 56: ATCC - Segment focus
  • 57: Becton, Dickinson and Co. - Overview
  • 58: Becton, Dickinson and Co. - Business segments
  • 59: Becton, Dickinson and Co. - Key offerings
  • 60: Becton, Dickinson and Co. - Key customers
  • 61: Becton, Dickinson and Co. - Segment focus
  • 62: Charles River Laboratories International Inc. - Overview
  • 63: Charles River Laboratories International Inc. - Product and service
  • 64: Charles River Laboratories International Inc. - Key offerings
  • 65: Charles River Laboratories International Inc. - Key customers
  • 66: Charles River Laboratories International Inc. - Segment focus
  • 67: F. Hoffmann-La Roche Ltd. - Overview
  • 68: F. Hoffmann-La Roche Ltd. - Business segments
  • 69: F. Hoffmann-La Roche Ltd. - Key offerings
  • 70: F. Hoffmann-La Roche Ltd. - Key customers
  • 71: F. Hoffmann-La Roche Ltd. - Segment focus
  • 72: InvivoGen - Overview
  • 73: InvivoGen - Business segments
  • 74: InvivoGen - Key offerings
  • 75: InvivoGen - Key customers
  • 76: InvivoGen - Segment focus
  • 77: Lonza Group Ltd. - Overview
  • 78: Lonza Group Ltd. - Business segments
  • 79: Lonza Group Ltd. - Key offerings
  • 80: Lonza Group Ltd. - Key customers
  • 81: Lonza Group Ltd. - Segment focus
  • 82: Merck KGaA - Overview
  • 83: Merck KGaA - Business segments
  • 84: Merck KGaA - Key offerings
  • 85: Merck KGaA - Key customers
  • 86: Merck KGaA - Segment focus
  • 87: Norgen Biotek Corp. - Overview
  • 88: Norgen Biotek Corp. - Product and service
  • 89: Norgen Biotek Corp. - Key offerings
  • 90: Norgen Biotek Corp. - Key customers
  • 91: Norgen Biotek Corp. - Segment focus
  • 92: Thermo Fisher Scientific Inc. - Overview
  • 93: Thermo Fisher Scientific Inc. - Business segments
  • 94: Thermo Fisher Scientific Inc. - Key offerings
  • 95: Thermo Fisher Scientific Inc. - Key customers
  • 96: Thermo Fisher Scientific Inc. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations